» Articles » PMID: 36530132

Investigating the Potential of Lipids for Use As Biomarkers for Glioblastoma Via an Untargeted Lipidomics Approach

Overview
Date 2022 Dec 19
PMID 36530132
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The types and functions of lipids involved in glioblastoma (GB) are not well known. Lipidomics is a new field that examines cellular lipids on a large scale and novel aplication of lipidomics in the biomedical sciences have emerged. This study aimed to investigate the potential of blood lipids for use as biomarkers for the diagnosis of GB via untargated lipidomic approach. Gaining a deeper understanding of lipid metabolism in patients with GB can contribute to the early diagnosis with GB patiens and also development of novel and better therapeutic options.

Methods: This study was performed using blood samples collected from 14 patients (eight females and six males) and 14 controls (eight females and six males). Lipids were extracted from blood samples and quantified using phosphorus assay. Lipid profiles of between patients with GB and controls were compared via an untargeted lipidomics approach using 6530 Accurate-Mass Q-TOF LC/MS mass spectrometer.

Results: According to the results obtained using the untargeted lipidomics approach, differentially regulated lipid species, including fatty acid (FA), glycerolipid (GL), glycerophospholipid (PG), saccharolipid (SL), sphingolipid (SP), and sterol lipid (ST) were identified between in patients with GB and controls.

Conclusion: Differentially regulated lipids were identified in patients with GB, and these lipid species were predicted as potential biomarkers for diagnosis of GB.

Citing Articles

Size matters: Biomolecular compositions of small and large extracellular vesicles in the urine of glioblastoma patients.

Hallal S, Sida L, Tuzesi C, Shivalingam B, Sim H, Buckland M J Extracell Biol. 2024; 3(11):e70021.

PMID: 39554867 PMC: 11565258. DOI: 10.1002/jex2.70021.


Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.

Seyhan A Int J Mol Sci. 2024; 25(14).

PMID: 39063215 PMC: 11277426. DOI: 10.3390/ijms25147974.


The Lipidomic Signature of Glioblastoma: A Promising Frontier in Cancer Research.

Yu N, Aboud O Cancers (Basel). 2024; 16(6).

PMID: 38539424 PMC: 10968728. DOI: 10.3390/cancers16061089.

References
1.
BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

2.
Zhou X, Mao J, Ai J, Deng Y, Roth M, Pound C . Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics. PLoS One. 2012; 7(11):e48889. PMC: 3495963. DOI: 10.1371/journal.pone.0048889. View

3.
Kinsey G, Blum J, Covington M, Cummings B, McHowat J, Schnellmann R . Decreased iPLA2gamma expression induces lipid peroxidation and cell death and sensitizes cells to oxidant-induced apoptosis. J Lipid Res. 2008; 49(7):1477-87. PMC: 2431104. DOI: 10.1194/jlr.M800030-JLR200. View

4.
Zhang R, Price J, Fujimaki T, Bucana C, Fidler I . Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice. Am J Pathol. 1992; 141(5):1115-24. PMC: 1886664. View

5.
Zhao Y, Cheng X, Lin R . Lipidomics applications for discovering biomarkers of diseases in clinical chemistry. Int Rev Cell Mol Biol. 2014; 313:1-26. DOI: 10.1016/B978-0-12-800177-6.00001-3. View